Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Arulkumar Nagappan, Jooyeon Shin, Myeong Ho Jung
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2109-2109
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Synthesis, structural, molecular docking and spectroscopic studies of (E)-N'-(4-methoxybenzylidene)-5-methyl-1H-pyrazole-3-carbohydrazide
Khalid Karrouchi, Silvia Antonia Brandán, Yusuf Sert, et al.
Journal of Molecular Structure (2020) Vol. 1225, pp. 129072-129072
Closed Access | Times Cited: 106
Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review
Qiming Tan, Camila E. Orsso, Edward C. Deehan, et al.
Obesity Reviews (2019) Vol. 21, Iss. 5
Closed Access | Times Cited: 71
Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update
Gabriella Dörnyei, Zsolt Vass, C. Juhàsz, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
Yane Costa Chaves, Karina Genaro, José Alexandre S. Crippa, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 4, pp. 639-652
Closed Access | Times Cited: 40
(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders
Jyoti Sihag, Vincenzo Di Marzo
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease
Dinesh Thapa, Anshu Ghimire, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 478-478
Open Access
Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights
M. Iqbal, Yu Qian, Jingqun Tang, et al.
Journal of Bacteriology (2025)
Open Access
Hydrogen peroxide as a signal for skeletal muscle adaptations to exercise: What do concentrations tell us about potential mechanisms?
Malcolm J. Jackson, Clare Stretton, Anne McArdle
Redox Biology (2020) Vol. 35, pp. 101484-101484
Open Access | Times Cited: 34
Assessment of spent hemp biomass as a potential ingredient in ruminant diet: nutritional quality and effect on performance, meat and carcass quality, and hematological parameters in finishing lambs
Nathan B. Parker, Massimo Bionaz, Hunter R. Ford, et al.
Journal of Animal Science (2022) Vol. 100, Iss. 10
Open Access | Times Cited: 20
Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
Ronald J. Ellis, Natalie Wilson, Scott N. Peterson
Viruses (2021) Vol. 13, Iss. 8, pp. 1521-1521
Open Access | Times Cited: 22
Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota
Francesco Suriano, Claudia Manca, Nicolas Flamand, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159056-159056
Open Access | Times Cited: 21
Hyperphagia in Prader-Willi syndrome with obesity: From development to pharmacological treatment
Qaddra Fahada Ab. Rahman, Nurul Farhana Jufri, Asmah Hamid
Intractable & Rare Diseases Research (2023) Vol. 12, Iss. 1, pp. 5-12
Open Access | Times Cited: 7
The Fight Against Obesity Escalates: New Drugs on the Horizon and Metabolic Implications
Dimitrios Tsilingiris, Stavros Liatis, Μaria Dalamaga, et al.
Current Obesity Reports (2020) Vol. 9, Iss. 2, pp. 136-149
Open Access | Times Cited: 19
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells
Mansour Haddad
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 3959-3967
Open Access | Times Cited: 17
Peripheral CB1R as a modulator of metabolic inflammation
Ji Hye Han, Wook Kim
The FASEB Journal (2021) Vol. 35, Iss. 4
Closed Access | Times Cited: 15
Targeting the endocannabinoid system in diabesity: Fact or fiction?
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1750-1758
Closed Access | Times Cited: 14
The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
Tomasz Charytoniuk, Hubert Żywno, Klaudia Berk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3083-3083
Open Access | Times Cited: 9
Recent advancements in pharmacological strategies to modulate energy balance for combating obesity
Benudhara Pati, Satyabrata Sendh, Bijayashree Sahu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 8, pp. 1429-1445
Open Access | Times Cited: 4
Characterization of the effects of cannabinoid receptor deletion on energy metabolism in female C57BL mice
Morgan Sotzen, Ahmed Ahmed, L. Karl Olson, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Brain endocannabinoid control of metabolic and non-metabolic feeding behaviors
Min Zhang, Qingyu Wang, Ying Wang
Neurochemistry International (2024) Vol. 183, pp. 105921-105921
Closed Access | Times Cited: 1
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway
Fei Ding, Chunping Qiu, Wenzhi Li, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 548, pp. 148-154
Open Access | Times Cited: 9
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
Gidion Wilson, Lingling Yang, Xiaojuan Su, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1410-1444
Closed Access | Times Cited: 3
Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis
Carmen Navarrete, Adela García‐Martin, Jim DeMesa, et al.
Current Hypertension Reports (2020) Vol. 22, Iss. 12
Closed Access | Times Cited: 8
A New Treatment Strategy for Diabetic Dyslipidemia?
Vishal Kothari, Karin Bornfeldt
Diabetes (2020) Vol. 69, Iss. 10, pp. 2061-2063
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top